Therefore, we have focused on the use of tranexamic acid (TXA), a drug introduced as early as 1968 for menorrhagia treatment [9], which works by slowing down the conversion of plasminogen to plasmin, subsequently, reducing fibrinolysis and stabilizing the blood clot. Here, PLG is linked to Menorrhagia.